Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Surgical Aortic Valve Replacement (STARC)
NCT05076019Recruiting
- Sponsor
- University Hospital Odense
- Start
- Feb 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Atrial fibrillation (AFib) comparing Atorvastatin 80 mg with Placebo (2 arms). Primary endpoints: Number of Participants with Postoperative Atrial Fibrillation - In-hospital up to 10 days, Number of Participants with Postoperative Atrial Fibrillation - Early at 30 days and 1 more. Started Feb 2022; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05076019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076019.